Sinochulumanco ukwazisa ukuba i-JYMed izakubonisa kwiVeki ye-Interphex eTokyo ukusuka nge-9 kaJulayi ukuya kowe-11 kaJulayi, ngo-2025, eTokyo Big Sight (Ariake). Lo msitho mkhulu udibanisa ababonisi abangaphezu kwama-90 kunye neengcali ezimalunga ne-34,000 ezivela kuwo wonke amashishini amayeza kunye nezithambiso. Njengelinye lamaqonga aphambili e-Asiya kushishino olutsha kunye neshishini lehlabathi, i-Interphex Tokyo lithuba eliphambili lentsebenziswano yamazwe ngamazwe.
Malunga JYMed
I-JYMed yinkampani yamayeza eqhutywa yisayensi egxile ekuphuhliseni, ekuveliseni, nasekurhwebeni kweemveliso ezisekwe kwipeptide. Sinikezela ngeenkonzo ze-CDMO zokuphela- ukuya esiphelweni kumayeza, ezozithambiso, kunye namaqabane onyango lwezilwanyana kwihlabathi liphela.
Iipotifoliyo zethu zemveliso ziquka uluhlu olubanzi lwe-peptide APIs, kuquka i-Semaglutide kunye ne-Tirzepatide, zombini eziye zagqiba ngempumelelo iifayili ze-US FDA DMF.
Ingalo yethu yokuvelisa, i-Hubei JXBio, isebenza kwimizila yemveliso ye-peptide API efikelela kwimigangatho ye-cGMP evela kuzo zombini i-US FDA kunye ne-NMPA yaseTshayina. Isiza sinemizila ye-10 emikhulu kunye ne-pilot-scale-scale kwaye ixhaswa yi-QMS eyomeleleyo kunye nesakhelo se-EHS esibanzi.
I-JXBio iphumelele uphicotho lwe-GMP yi-FDA yase-US kunye ne-NMPA yaseTshayina kwaye yamkelwa ziinkampani ezikhokela amayeza ngokuzinikela kwayo kukhuseleko, umgangatho, kunye noxanduva lokusingqongileyo.
IIMVELISO EZIPHAMBILI
MasiQhagamshele
Ukufunda ngakumbi ngezakhono zethu okanye ukucwangcisa intlanganiso ngexesha lomboniso:
•Global API & Cosmetic Imibuzo:+ 86-150-1352-9272
•Ubhaliso lwe-API kunye neeNkonzo zeCDMO (US & EU):+ 86-158-1868-2250
•I-imeyile: jymed@jymedtech.com
•Idilesi:Imigangatho ye-8 & 9, iSakhiwo 1, i-Shenzhen Biomedical Innovation Industrial Park, i-14 Jinhui Road, iSithili saseKengzi, iSithili sasePingshan, iShenzhen, eChina.
Ixesha lokuposa: Jul-05-2025



